Magee Thomson Investment Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Magee Thomson Investment Partners's CELG Position: Q1 2017 in Review
Magee Thomson Investment Partners reduced its Celgene Corp (CELG) stake by 19% in Q1 2017, selling an estimated $3.28M and leaving 117,400 shares worth $14.6M. The position accounts for 5.64% of the portfolio, ranked #4.
Magee Thomson Investment Partners first reported a position in CELG in Q4 2014 and has held it in 10 quarters since. The position peaked at $16.8M in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.
- Magee Thomson Investment Partners held 117,400 shares of Celgene Corp worth $14.6M as of Q1 2017.
- Magee Thomson Investment Partners sold 27,400 Celgene Corp shares in Q1 2017, an estimated $3.28M.
- Celgene Corp made up 5.64% of Magee Thomson Investment Partners's portfolio in Q1 2017, its #4 holding.
- Magee Thomson Investment Partners first reported a position in Celgene Corp in Q4 2014 and has held it in 10 quarters since.
- Magee Thomson Investment Partners's Celgene Corp position peaked at $16.8M in Q4 2016.
- 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.
Based on Magee Thomson Investment Partners's 13F filing for Q1 2017, filed 21 Apr 2017.